中国医药
中國醫藥
중국의약
CHINA MEDICINE
2013年
7期
900-902
,共3页
黄信生%顾承雄%韦华%杨俊峰%方颖%刘锐%周其文
黃信生%顧承雄%韋華%楊俊峰%方穎%劉銳%週其文
황신생%고승웅%위화%양준봉%방영%류예%주기문
冠心病%C反应蛋白%冠状动脉旁路移植术
冠心病%C反應蛋白%冠狀動脈徬路移植術
관심병%C반응단백%관상동맥방로이식술
Coronary heart disease%C-reactive protein%Coronary artery bypass surgery
目的 探讨术前血清C反应蛋白水平对非体外循环下冠状动脉旁路移植术临床疗效的影响.方法 将734例行非体外循环下冠状动脉旁路移植术的冠心病患者根据术前C反应蛋白水平分为CRP≥3.0 mg/L组(386例)和CRP <3.0 mg/L组(348例),记录术后心血管事件发生情况,Logistic回归分析影响预后的相关因素.结果 术后30 d内CRP≥3.0 mg/L组心血管事件发生率[4.9%(19例)]高于CRP<3.0 mg/L组[4.0%(14例)],但差异无统计学意义(P>0.05);平均随访(5.2±1.8)年,CRP≥3.0 mg/L组心血管事件发生率[22.0%(78例)]明显高于CRP< 3.0 mg/L组[12.2% (40例)],差异有统计学意义(P<0.05),Logistic回归分析示:CRP≥3.0 mg/L不能预测术后30 d心血管事件发生情况,但是预测术后远期心血管事件最强因子,COX分析术前CRP≥3.0 mg/L是影响患者预后的危险因素,其次左心室射血分数<45%.CRP≥3.0 mg/L组5年实际生存率明显低于CRP <3.0 mg/L组[(90.0±1.2)%比(94.0±0.8)%,P<0.05].CRP≥3.0 mg/L和左心室射血分数<45%二者合并的患者5年生存率明显降低(88.0±0.4)%.结论 血清C反应蛋白水平可以预测非体外循环下冠状动脉旁路移植术的远期临床疗效,提示血管壁的炎症程度与远期疗效相关.
目的 探討術前血清C反應蛋白水平對非體外循環下冠狀動脈徬路移植術臨床療效的影響.方法 將734例行非體外循環下冠狀動脈徬路移植術的冠心病患者根據術前C反應蛋白水平分為CRP≥3.0 mg/L組(386例)和CRP <3.0 mg/L組(348例),記錄術後心血管事件髮生情況,Logistic迴歸分析影響預後的相關因素.結果 術後30 d內CRP≥3.0 mg/L組心血管事件髮生率[4.9%(19例)]高于CRP<3.0 mg/L組[4.0%(14例)],但差異無統計學意義(P>0.05);平均隨訪(5.2±1.8)年,CRP≥3.0 mg/L組心血管事件髮生率[22.0%(78例)]明顯高于CRP< 3.0 mg/L組[12.2% (40例)],差異有統計學意義(P<0.05),Logistic迴歸分析示:CRP≥3.0 mg/L不能預測術後30 d心血管事件髮生情況,但是預測術後遠期心血管事件最彊因子,COX分析術前CRP≥3.0 mg/L是影響患者預後的危險因素,其次左心室射血分數<45%.CRP≥3.0 mg/L組5年實際生存率明顯低于CRP <3.0 mg/L組[(90.0±1.2)%比(94.0±0.8)%,P<0.05].CRP≥3.0 mg/L和左心室射血分數<45%二者閤併的患者5年生存率明顯降低(88.0±0.4)%.結論 血清C反應蛋白水平可以預測非體外循環下冠狀動脈徬路移植術的遠期臨床療效,提示血管壁的炎癥程度與遠期療效相關.
목적 탐토술전혈청C반응단백수평대비체외순배하관상동맥방로이식술림상료효적영향.방법 장734례행비체외순배하관상동맥방로이식술적관심병환자근거술전C반응단백수평분위CRP≥3.0 mg/L조(386례)화CRP <3.0 mg/L조(348례),기록술후심혈관사건발생정황,Logistic회귀분석영향예후적상관인소.결과 술후30 d내CRP≥3.0 mg/L조심혈관사건발생솔[4.9%(19례)]고우CRP<3.0 mg/L조[4.0%(14례)],단차이무통계학의의(P>0.05);평균수방(5.2±1.8)년,CRP≥3.0 mg/L조심혈관사건발생솔[22.0%(78례)]명현고우CRP< 3.0 mg/L조[12.2% (40례)],차이유통계학의의(P<0.05),Logistic회귀분석시:CRP≥3.0 mg/L불능예측술후30 d심혈관사건발생정황,단시예측술후원기심혈관사건최강인자,COX분석술전CRP≥3.0 mg/L시영향환자예후적위험인소,기차좌심실사혈분수<45%.CRP≥3.0 mg/L조5년실제생존솔명현저우CRP <3.0 mg/L조[(90.0±1.2)%비(94.0±0.8)%,P<0.05].CRP≥3.0 mg/L화좌심실사혈분수<45%이자합병적환자5년생존솔명현강저(88.0±0.4)%.결론 혈청C반응단백수평가이예측비체외순배하관상동맥방로이식술적원기림상료효,제시혈관벽적염증정도여원기료효상관.
Objective To investigate the relationship between serum levels of C-reactive protein(CRP) and cardiovascular events in patients with coronary heart disease after off-pump coronary artery bypass grafting.Methods From January 2002 to January 2007,we investigated 734 patients who underwent off-pump coronary artery bypass surgery.Preprocedural serum levels of CRP were measured in patients.According to the level of CRP,the patients were divided into two groups:CRP ≥3.0 mg/L-group (386 cases) and CRP < 3.0 mg/L group (348 cases).The cardiovascular events (angina pectoris,myocardial infarction and death) was carefully observed and recorded after the procedures.Results The incidence of early outcome was not significant between CRP ≥ 3.0 mg/L group and CRP < 3.0 mg/L group at postoperative 30 days (4.9% vs 4.3%,P > 0.05).Follow-up period was mean (5.2 ± 1.8) years.The frequency of cardiovascular events was significantly higher in CRP≥3.0 mg/L group than that in CRP<3.0 mg/L group (22.0% vs 12.2%,P <0.05).Multivariate analysis showed that preoperative CRP≥ 3.0 mg/L did not seem to be an useful marker in predicting outcome after postoperative 30 days,But it was an independent predictor of late cardiovascular events.COX proportional hazards models showed that CRP≥3.0 mg/L was an independent predictor of late cardiovascular events,followed by left ventricular ejection fraction < 45%.Among operative survivors,patients in CRP < 3.0 mg/L group had significantly higher 5-year overall survival rate than those in CRP ≥ 3.0 mg/L group [(94.0 ± 0.8) % vs (90.0 ± 1.2) %,P < 0.05],CRP ≥ 3.0 mg/L combined with left ventricular ejection fraction < 45% were associated with significantly decreased overall survival after procedure (88.0 ± 0.4) %.Conclusions Serum levels of CRP may be a predictive of cardiovascular events in patients with coronary heart disease after off-pump coronary artery bypass grafting.It indicates that long-term clinical outcomes are related to the enhanced inflammatory response of blood vessel.